Burkhard Gess

1.6k total citations
44 papers, 887 citations indexed

About

Burkhard Gess is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Burkhard Gess has authored 44 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cellular and Molecular Neuroscience, 16 papers in Neurology and 8 papers in Molecular Biology. Recurrent topics in Burkhard Gess's work include Hereditary Neurological Disorders (21 papers), Botulinum Toxin and Related Neurological Disorders (8 papers) and Genetic Neurodegenerative Diseases (7 papers). Burkhard Gess is often cited by papers focused on Hereditary Neurological Disorders (21 papers), Botulinum Toxin and Related Neurological Disorders (8 papers) and Genetic Neurodegenerative Diseases (7 papers). Burkhard Gess collaborates with scholars based in Germany, United States and Austria. Burkhard Gess's co-authors include Peter Young, Hartmut Halfter, Jan‐Kolja Strecker, Anja Schirmacher, Matthias Schilling, Matthias Boentert, Jens Minnerup, Wolf‐Rüdiger Schäbitz, Ilka Kleffner and E. Bernd Ringelstein and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Burkhard Gess

44 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Burkhard Gess Germany 18 347 214 203 196 115 44 887
Д. Э. Коржевский Russia 17 298 0.9× 416 1.9× 83 0.4× 348 1.8× 64 0.6× 257 1.2k
Eirini Vagena United States 10 173 0.5× 229 1.1× 102 0.5× 216 1.1× 37 0.3× 16 851
Akira Inaba Japan 13 282 0.8× 253 1.2× 510 2.5× 131 0.7× 74 0.6× 43 1.0k
Toshihiro Mashiko Japan 13 280 0.8× 308 1.4× 242 1.2× 85 0.4× 130 1.1× 22 1.0k
Arjun Khanna United States 16 372 1.1× 496 2.3× 101 0.5× 70 0.4× 60 0.5× 23 1.0k
Nicolas C. Royo United States 20 284 0.8× 376 1.8× 412 2.0× 112 0.6× 36 0.3× 26 1.0k
Jan‐Kolja Strecker Germany 22 171 0.5× 302 1.4× 140 0.7× 798 4.1× 57 0.5× 37 1.4k
Bin Yao United States 17 300 0.9× 323 1.5× 173 0.9× 153 0.8× 20 0.2× 40 1.0k
Ruslan Rust Switzerland 17 179 0.5× 294 1.4× 106 0.5× 386 2.0× 21 0.2× 49 974
Raghu Vemuganti United States 17 276 0.8× 589 2.8× 163 0.8× 329 1.7× 30 0.3× 22 1.3k

Countries citing papers authored by Burkhard Gess

Since Specialization
Citations

This map shows the geographic impact of Burkhard Gess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burkhard Gess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burkhard Gess more than expected).

Fields of papers citing papers by Burkhard Gess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burkhard Gess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burkhard Gess. The network helps show where Burkhard Gess may publish in the future.

Co-authorship network of co-authors of Burkhard Gess

This figure shows the co-authorship network connecting the top 25 collaborators of Burkhard Gess. A scholar is included among the top collaborators of Burkhard Gess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burkhard Gess. Burkhard Gess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rogalewski, Andreas, et al.. (2024). Functional long-term outcome following endovascular thrombectomy in patients with acute ischemic stroke. SHILAP Revista de lepidopterología. 6(1). 2–2. 3 indexed citations
2.
Gess, Burkhard, et al.. (2023). Carbamazepine for Chronic Muscle Pain: A Retrospective Assessment of Indications, Side Effects, and Treatment Response. Brain Sciences. 13(1). 123–123. 3 indexed citations
3.
Schröter, Rita, C Ceresa, A Chiorazzi, et al.. (2023). Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin. International Journal of Molecular Sciences. 24(14). 11486–11486. 2 indexed citations
4.
Jennings, Matthew J., Alexia Kagiava, Leen Vendredy, et al.. (2022). NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice. Brain. 145(11). 3999–4015. 26 indexed citations
5.
Gadermayr, Michael, Kexin Li, Madlaine Müller, et al.. (2021). Image-to-Image Translation for Simplified MRI Muscle Segmentation. PubMed. 1. 664444–664444. 4 indexed citations
7.
Dohrn, Maike F., et al.. (2020). Immunoglobulins to mitigate paraneoplastic Lambert Eaton Myasthenic Syndrome under checkpoint inhibition in Merkel cell carcinoma. SHILAP Revista de lepidopterología. 2(1). 52–52. 16 indexed citations
8.
Portugal, Camila C., Renato Socodato, Teresa Canedo, et al.. (2017). Caveolin-1–mediated internalization of the vitamin C transporter SVCT2 in microglia triggers an inflammatory phenotype. Science Signaling. 10(472). 58 indexed citations
9.
Gadermayr, Michael, et al.. (2017). A comprehensive study on automated muscle segmentation for assessing fat infiltration in neuromuscular diseases. Magnetic Resonance Imaging. 48. 20–26. 26 indexed citations
10.
Bihel, Frédéric, Burkhard Gess, & Michel Fontés. (2016). CMTX Disorder and CamKinase. Frontiers in Cellular Neuroscience. 10. 49–49. 3 indexed citations
11.
Kleffner, Ilka, Burkhard Gess, Catharina Korsukewitz, et al.. (2015). Behr syndrome with homozygous C19ORF12 mutation. Journal of the Neurological Sciences. 357(1-2). 115–118. 15 indexed citations
12.
Gess, Burkhard, et al.. (2014). Desmoplakin is involved in organization of an adhesion complex in peripheral nerve regeneration after injury. Experimental Neurology. 264. 55–66. 5 indexed citations
13.
Rosso, Gonzalo, Ivan Liashkovich, Burkhard Gess, et al.. (2014). Unravelling crucial biomechanical resilience of myelinated peripheral nerve fibres provided by the Schwann cell basal lamina and PMP22. Scientific Reports. 4(1). 7286–7286. 40 indexed citations
14.
Gess, Burkhard, et al.. (2013). Ascorbic Acid and Sodium-Dependent Vitamin C Transporters in the Peripheral Nervous System: From Basic Science to Clinical Trials. Antioxidants and Redox Signaling. 19(17). 2105–2114. 12 indexed citations
15.
Gess, Burkhard, Anja Schirmacher, & Peter Young. (2013). Genetik der Neuropathien. Der Nervenarzt. 84(2). 157–165. 3 indexed citations
16.
Boentert, Matthias, et al.. (2013). Sleep disorders in Charcot-Marie-Tooth disease type 1. Journal of Neurology Neurosurgery & Psychiatry. 85(3). 319–325. 31 indexed citations
17.
Gess, Burkhard, Astrid Jeibmann, Anja Schirmacher, et al.. (2011). REPORT of a novel mutation in the PMP22 gene causing an axonal neuropathy. Muscle & Nerve. 43(4). 605–609. 14 indexed citations
18.
Strecker, Jan‐Kolja, Jens Minnerup, Burkhard Gess, et al.. (2011). Monocyte Chemoattractant Protein-1-Deficiency Impairs the Expression of IL-6, IL-1β and G-CSF after Transient Focal Ischemia in Mice. PLoS ONE. 6(10). e25863–e25863. 55 indexed citations
19.
Gess, Burkhard, Robert Fledrich, Michael W. Sereda, et al.. (2011). Sodium-Dependent Vitamin C Transporter 2 Deficiency Causes Hypomyelination and Extracellular Matrix Defects in the Peripheral Nervous System. Journal of Neuroscience. 31(47). 17180–17192. 36 indexed citations
20.
Gess, Burkhard, et al.. (2009). Sodium‐dependent vitamin C transporter 2 (SVCT2) is necessary for the uptake of L‐ascorbic acid into Schwann cells. Glia. 58(3). 287–299. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026